RSLDX
Price
$73.48
Change
-$0.78 (-1.05%)
Updated
Jul 11 closing price
Net Assets
78.5B
RTXAX
Price
$12.77
Change
-$0.02 (-0.16%)
Updated
Jul 11 closing price
Net Assets
1.12B
Interact to see
Advertisement

RSLDX vs RTXAX

Header iconRSLDX vs RTXAX Comparison
Open Charts RSLDX vs RTXAXBanner chart's image
American Funds SMALLCAP World R5E
Price$73.48
Change-$0.78 (-1.05%)
VolumeN/A
Net Assets78.5B
Russell Inv Tax-Managed Real Assets A
Price$12.77
Change-$0.02 (-0.16%)
VolumeN/A
Net Assets1.12B
RSLDX vs RTXAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSLDX vs. RTXAX commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLDX is a Buy and RTXAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 78.5B vs. RTXAX (1.12B). RTXAX pays higher dividends than RSLDX: RTXAX (1.97) vs RSLDX (0.81). RSLDX was incepted earlier than RTXAX: RSLDX (10 years) vs RTXAX (6 years). RTXAX (1.42) is less costly to investors than RSLDX (0.80). RTXAX is a more actively managed with annual turnover of: 42.00 vs. RSLDX (32.00). RTXAX has a lower initial minimum investment than RSLDX: RTXAX (0) vs RSLDX (250). RSLDX annual gain was more profitable for investors over the last year : 7.32 vs. RTXAX (5.22). RTXAX return over 5 years is better than : 52.20 vs. RSLDX (19.88).
RSLDXRTXAXRSLDX / RTXAX
Total Expense Ratio0.801.3360%
Annual Report Gross Expense Ratio0.801.4256%
Fund Existence10 years6 years-
Gain YTD7.9515.800137%
Front LoadN/A6%-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets78.5B1.12B7,021%
Annual Yield % from dividends0.811.9741%
Returns for 1 year7.325.22140%
Returns for 3 years35.5016.76212%
Returns for 5 years19.8852.2038%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLRX1.410.01
+0.71%
Pliant Therapeutics
FFIV291.89-8.00
-2.67%
F5, Inc.
DNLI14.52-0.83
-5.41%
Denali Therapeutics
UUU3.33-0.23
-6.33%
Universal Security Instruments
PLSE16.03-1.09
-6.37%
Pulse Biosciences